PI
Cancer Center Amsterdam
-
Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial: Authors' reply
CROSSFIRE study investigators, 1 Aug 2024, In: The Lancet Gastroenterology and Hepatology. 9, 8, p. 687-688 2 p.Research output: Contribution to journal › Letter › Academic › peer-review
-
Hybrid operating room applications for precision hepatobiliary surgery: A narrative review
Pilz da Cunha, G., van Delden, O. M., Kazemier, G., Vahrmeijer, A. L., Bonjer, H. J., Meijerink, M. R. & Swijnenburg, R-J., Jun 2024, In: Journal of surgical oncology. 129, 7, p. 1265-1273 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial
Timmer, F. E. F., Geboers, B., Ruarus, A. H., Vroomen, L. G. P. H., Schouten, E. A. C., van der Lei, S., Vos, D. J. W., Dijkstra, M., Schulz, H. H., Bakker, J., van den Bemd, B. A. T., van den Tol, P. M., Puijk, R. S., Lissenberg-Witte, B. I., de Gruijl, T. D., de Vries, J. J. J., Lagerwaard, F. J., Scheffer, H. J., Bruynzeel, A. M. E. & Meijerink, M. R., 1 May 2024, In: The Lancet Gastroenterology and Hepatology. 9, 5, p. 448-459 12 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications